Learn More
Medchemexpress LLC SE-7552 | 2243575-79-1 | 99.5% | 335.28 | 1 ML

Supplier: Medchemexpress LLC HY16130510MM/1ML
SE-7552, a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-hydroxamate HDAC6 inhibitor with an IC50 of 33 nM. It demonstrates greater than 850-fold selectivity versus all other known HDAC isozymes. This compound is capable of blocking multiple myeloma growth in vivo and acts as an anti-obesity agent in diet-induced obese mice.
- High selectivity for HDAC6
- Oral activity
- Non-hydroxamate nature
- Shown efficacy in blocking multiple myeloma growth in vivo
- Acts as an anti-obesity agent
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.